Design, development and optimization of oral colon targeted drug delivery system of azathioprine using biodegradable polymers

Pharmaceutical Development and Technology

Volumn 18, Issue 5, 2013, Pages 1131-1139

  Nath, Bipul ^a,b   Nath, L K ^b  

^a GAUHATI UNIVERSITY   (India)

^b DIBRUGARH UNIVERSITY   (India)

Author keywords

Biodegradable; Chitosan; Colon targeted; Sterculia gum; Swellable core

Indexed keywords

AZATHIOPRINE; CHITOSAN; EUDRAGIT; MACROGOL 400; POLYSACCHARIDE; STERCULIA GUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DESIGN; DRUG RELEASE; DRUG SOLUBILITY; ENTERIC COATED TABLET; FILM COATING; INTESTINE FLUID; MALE; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT; STERCULIA; STOMACH JUICE; TABLET FORMULATION; TABLET MACHINE;

ADMINISTRATION, ORAL; ANIMALS; AZATHIOPRINE; CECUM; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; COLON; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; MALE; POLYMERS; POLYMETHACRYLIC ACIDS; POLYSACCHARIDES; RATS; RATS, WISTAR; STERCULIA; TABLETS;

EID: 84887452018     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2012.727002     Document Type: Article

References (26)

1. Jain A, Gupta Y, Jain SK. Perspectives of biodegradable natural polysaccharides for site-specifc drug delivery to the colon. J Pharm Pharm Sci 2007;10:86-128.
2. Pantel N, Patel J, Gandhi T, Shah S. Novel pharmaceutical approach for colon-specifc drug delivery: an overview. J Pharm Res 2008;1:2-10.
3. Kwonho K, Kaur K. Studies of chitosan/organic acid/Eudragit® RS/RL-coated system for colonic delivery. Int J Pharm 2009;366:140-148.
4. Chang YZ, Wei H, Ming Q, Cao DY. Studies of chitosan/Kollicoat SR 30D flm-coated tablets for colonic drug delivery. Int J Pharm 2009;375:8-15.
5. British Pharmacopoeia. (2009). General Notices and Monograph: Powdered Sterculia and Sterculia gum. 34th ed. London U. K: British Pharmacopoeial Commission, 3735-3736.
6. Babu MM, Prasad CS, Rama Murthy KV. Evaluation of modifed gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine. Int J Pharm 2002; 234:1-17.
7. Kenneth C, Waterman BC, MacDonald MC. Extrudable core system: Development of a single-layer osmotic controlled-release tablet. J Control Release 2009;134:201-206.
8. Lu EX, Jiang ZQ, Zhang QZ, Jiang XG. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent. J Control Release 2003;92:375-382.
9. Singh BN, Kim KH. Characterization and relevance of physicochemical interactions among components of a novel multiparticulate formulation for colonic delivery. Int J Pharm 2007;341:143-151.
10. Sandborn WJ, Bonnie H, Goldlust B, Goldberg AH. Targeted delivery of azathioprine (AZA) to the ileum and colon for the treatment of Crohn's disease (CD): Scintigraphic and pharmacokinetic (PK) evaluation of a novel azathioprine delayed-release (AZA-DR) formulation. Gastroenterology 2001;120:625-629.
11. Katsuma M, Watanabe S, Kawai H, Takemura S, Masuda Y, Fukui M. Studies on lactulose formulations for colon-specifc drug delivery. Int J Pharm 2002;249:33-43.
12. Zhang H, Neau SH. In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents. Biomaterials 2002;23:2761-2766.
13. Jaleh V, Naser T, Fatemeh K. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of Tramadol Hydrochloride. AAPS Pharm Sci Tech 2006;7:E1-E7.
14. Schilling SU, Bruce CD, Shah NH, Malick AW, McGinity JW. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets. Int J Pharm 2008;361:158-168.
15. Banker SG, Christopher RT. (2002). Optimization techniques of pharmaceutical formulation and processing. Modern Pharmaceutics. 4th ed. (revised and expanded). New York: Marcel Dekker Inc, 1-20.
16. The United States Pharmacopeia. (2005). 29th ed. Toronto: The United States Pharmacopeial Convention Rockville, council of experts and Board of Trustee, 2246-2249.
17. Sujja-areevath J, Munday DL, Cox PJ, Khan KA. Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations. Eur J Pharm Sci 1998;6:207-217.
18. Yang L. Biorelevant dissolution testing of colon-specifc delivery systems activated by colonic microfora. J Control Release 2008;125:77-86.
19. Pandey P, Turton R, Joshi N, Hammerman E, Ergun J. Scale-up of a pan-coating process. AAPS PharmSciTech 2006;7:102.
20. Akhgari FS, Afrasiabi GH. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int J Pharm 2006;320:137-142.
21. Raghavan C V, Muthulingam C, Jenita JA, Ravi TK. An in vitro and in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting. Chem Pharm Bull 2002;50:892-895.
22. Kramar A, Turk S, Vrecer F. Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic flms. Int J Pharm 2003;256:43-52.
23. Kotagale N, Maniyar M, Somvanshi S, Umekar M, Patel CJ. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine. Pharm Dev Technol 2010;15:431-437.
24. Marucci M, Ragnarsson G, Nyman U, Axelsson A. Mechanistic model for drug release during the lag phase from pellets coated with a semi-permeable membrane. J Control Release 2008;127:31-40.
25. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profles. Eur J Pharm Sci 2001;13:123-133.
26. Cartensen JT, Rhodes CT. (2010). Stability study of pharmaceuticals. Drug Stability, Principles and Practices, (revised and expanded, Indian reprint). 3rd ed. New York: Informa Healthcare, 358-365.